Drugmaker Eli Lilly and Co. (LLY), while reporting third-quarter adjusted earnings and revenues below market estimates, on Wednesday lowered its forecast for fiscal 2024 earnings and revenues.
On a reported basis,the company turned around to profit in its third quarter on strong revenue growth.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com